mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.8 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.8 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |